Clinical Trials Browser

Phase 2 × Hodgkin Disease × Arsenic Trioxide × Clear all

NCT00005595 2012-06-11

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease

Phase 2 Terminated

Hodgkin Disease, Lymphoma